Compare Revvity Inc (RVTY) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Wayfair Inc — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while Wayfair Inc trades at $102.74 (market cap $14.14B). The key difference: Revvity Inc and Wayfair Inc are close in size by market cap, and Revvity Inc pays a 0.24% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| RVTY | W | |
|---|---|---|
Market Cap | $12.91B | $14.14B |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.75 | $119.05 |
52-Week Low | $82.26 | $57.40 |
Enterprise Value | $15.23B | $16.47B |
Dividend Yield | 0.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Wayfair (W) trades at $102.79, down 0.52% on the day, with a bullish technical signal supported by a golden cross and recent 30% post-earnings rally. Q2 2026 EPS of $0.95 beat estimates, driven by 7.5% revenue growth and strong U.S. demand, though net margins remain negative. Analyst consensus is bullish with a $122 price target, citing market share gains and margin expansion prospects.
Outlook: Growth momentum and positive sentiment offer upside potential, but risks include persistent losses, high debt-to-asset ratio (95.11% in 2025), and volatile consumer spending. Investors should weigh robust U.S. performance against international weakness and profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
